James C Hamilton Arrowhead Pharmaceuticals, Inc. (ARWR) insider trading activity

ARWR Quotes by TradingView

James C Hamilton is Chief Medical Officer of ARROWHEAD PHARMACEUTICALS, INC.. Currently has a direct ownership of 212,122 shares of ARWR, which is worth approximately $8.75 Million. The most recent transaction as insider was on Oct 01, 2025, when has been sold 20,000 shares (Common Stock) at a price of $35.0 per share, resulting in proceeds of $700,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 212K
0% 3M change
3.55% 12M change
Total Value Held $8.75 Million

James C Hamilton Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 01 2025
SELL
Open market or private sale
$700,000 $35.0 p/Share
20,000 Reduced 8.62%
212,122 Common Stock
Sep 12 2025
SELL
Open market or private sale
$450,000 $30.0 p/Share
15,000 Reduced 6.07%
232,122 Common Stock
Sep 02 2025
SELL
Open market or private sale
$375,000 $25.0 p/Share
15,000 Reduced 5.72%
247,122 Common Stock
Aug 15 2025
SELL
Open market or private sale
$187,780 $20.0 p/Share
9,389 Reduced 3.46%
262,122 Common Stock
Aug 13 2025
SELL
Open market or private sale
$12,220 $20.0 p/Share
611 Reduced 0.22%
271,511 Common Stock
Jan 06 2025
SELL
Open market or private sale
$651,307 $19.9 p/Share
32,729 Reduced 10.74%
272,122 Common Stock
Jan 04 2025
BUY
Grant, award, or other acquisition
-
100,000 Added 24.7%
304,851 Common Stock
Apr 01 2024
SELL
Open market or private sale
$168,180 $28.03 p/Share
6,000 Reduced 2.85%
204,851 Common Stock
Jan 12 2024
SELL
Open market or private sale
$293,144 $36.92 p/Share
7,940 Reduced 3.63%
210,851 Common Stock
Jan 05 2024
SELL
Open market or private sale
$1,121,790 $34.9 p/Share
32,143 Reduced 12.81%
218,791 Common Stock
Jan 04 2024
BUY
Grant, award, or other acquisition
-
75,000 Added 23.01%
250,934 Common Stock
Jan 03 2024
SELL
Open market or private sale
$205,002 $32.54 p/Share
6,300 Reduced 3.46%
175,934 Common Stock
Jun 30 2023
SELL
Open market or private sale
$106,590 $35.53 p/Share
3,000 Reduced 1.57%
188,484 Common Stock
Jan 05 2023
SELL
Open market or private sale
$516,232 $37.4 p/Share
13,803 Reduced 6.72%
191,484 Common Stock
Jan 04 2023
BUY
Grant, award, or other acquisition
-
60,000 Added 22.62%
205,287 Common Stock
Jan 03 2023
SELL
Open market or private sale
$403,698 $39.05 p/Share
10,338 Reduced 6.64%
145,287 Common Stock
Jan 05 2022
SELL
Open market or private sale
$391,250 $62.6 p/Share
6,250 Reduced 3.86%
155,625 Common Stock
Jan 04 2022
SELL
Open market or private sale
$1,299,481 $67.07 p/Share
19,375 Reduced 10.69%
161,875 Common Stock
Jan 01 2022
BUY
Grant, award, or other acquisition
-
55,000 Added 23.28%
181,250 Common Stock
Jan 14 2021
SELL
Open market or private sale
$814,000 $81.4 p/Share
10,000 Reduced 7.34%
126,250 Common Stock
Jan 06 2021
SELL
Open market or private sale
$1,392,481 $71.87 p/Share
19,375 Reduced 12.45%
136,250 Common Stock
Jan 05 2021
SELL
Open market or private sale
$1,405,269 $72.53 p/Share
19,375 Reduced 11.07%
155,625 Common Stock
Jan 01 2021
BUY
Grant, award, or other acquisition
-
50,000 Added 22.22%
175,000 Common Stock
JCH

James C Hamilton

Chief Medical Officer
Pasadena, CA

Track Institutional and Insider Activities on ARWR

Follow ARROWHEAD PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARWR shares.

Notify only if

Insider Trading

Get notified when an Arrowhead Pharmaceuticals, Inc. insider buys or sells ARWR shares.

Notify only if

News

Receive news related to ARROWHEAD PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ARWR